Active Ingredient History

  • Now
Phenylbutazone is an anti-inflammatory drug, which binds to and inactivates cyclooxygenases and prostacyclin synthase through peroxide (H2O2) mediated deactivation. The reduced production of prostaglandin leads to reduced inflammation of the surrounding tissues. Phenylbutazone was marked under the brand name butazolidin for the treatment rheumatoid arthritis and gout, but then this usage was discontinued. In addition, phenylbutazone is used in UK for the treatment of ankylosing spondylitis, but only in those cases, when other therapies are unsuitable.   NCATS

  • Mol. Mass: 308.3743
  • ALogP: 3.79
  • ChEMBL Molecules:
More Chemistry
3,5-dioxo-1,2-diphenyl-4-n-butylpyrazolidine | 4-butyl-1,2-diphenyl-pyrazolidine-3,5-dione | 4-n-butyl-1,2-diphenyl-3,5-pyrazolidinedione | antadol | azolid | butacote | butaject | butazolidin | diphenylbutazone | elmedal | equiphar | fenilbutazona | phenbutazone | phenylbutazon | phenylbutazone | phenylbutazonum | pro-bute


Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue